In this lecture dr Marlies Wakkee, dermatologist and associate professor at the Erasmus MC Cancer Institute, describes how care, research and teaching are set out from a broad perspective. This ranges from feeling responsible for organising optimal care for all skin cancer patients in the Netherlands to investigating advanced skin cancer by innovative, translational research lines and collaborating with external partners like the Erasmus School of Health Policy and Management and TU Delft within the Convergence and various public private partnerships.
Joining the forces and expertise of clinicians, laboratory specialists and scientists is essential in providing the best care for people with hereditary and familial tumors. Erasmus MC’s ‘Academic Center for Familial and Hereditary tumors’ brings these groups together.
Already 20 years ago, the first study on gene therapy for the bleeding disorder hemophilia B was published. Internist-hematologist Prof Dr Frank Leebeek explains what has happened since then. Is gene therapy the cure for the royal disease?